Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

NCT06007508 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT06007508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06007508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Lead sponsor
HealthPartners Institute
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2022
Completion date
February 28, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dka